Latest News
GSK's RSV Vaccine Advances in Chinese Regulatory Review, Eyes 2027 Decision
GSK's Arexvy RSV vaccine application has been accepted for review by China's drug regulator, with a potential approval decision expected in 2027. The stock edged higher as JPMorgan raised its price target and the company's dividend ex-date approaches.
Barclays Initiates £1 Billion Buyback Amid Profit Growth and U.S. Fee Concerns
Barclays has commenced a £1 billion share repurchase program following a 12% rise in annual pretax profit, while investors monitor regulatory risks to its U.S. card operations.
Indian Indices Climb on Trade Deal Hopes, Domestic Buying Offsets Foreign Outflows
Indian benchmarks advanced Wednesday, with the Nifty50 nearing 26,000, buoyed by optimism over a potential India-US trade agreement and significant net purchases by domestic institutions.
Lumentum Shares Slide in Extended Trading Ahead of Key Investor Conferences
Lumentum Holdings stock declined 2.8% in after-hours trading following a volatile session, as investors await management commentary at upcoming Susquehanna and Morgan Stanley events.
ServiceNow Leads Software Rebound as Analysts Cite AI Overreaction
ServiceNow shares climbed 2.5% to $106.48, leading a broader software recovery after a recent selloff. JPMorgan and Morgan Stanley analysts attributed the decline to sentiment-driven AI fears rather than fundamental weakness.
JPMorgan Shares Slip Ahead of Jobs Data; Executive Highlights Strong Deal Outlook
JPMorgan Chase shares declined 1.2% amid broader market weakness as investors awaited key employment figures. An executive noted the bank's deal pipeline remains robust through 2026.
AppLovin Shares Gain Ahead of Q4 Report Amid Analyst Target Adjustments
AppLovin's stock advanced 2.7% in extended trading Tuesday, continuing a rebound as investors await quarterly results. UBS trimmed its price target but maintained a Buy rating, citing strength in the company's ad technology.
MSTR Shares Slide After-Hours as Bitcoin Purchase Strategy Continues
Strategy Inc shares fell roughly 4% in extended trading following a new bitcoin acquisition and comments from Chairman Michael Saylor reaffirming the company's crypto-focused approach.
Apple Shares Dip Slightly After Hours as Bernstein Boosts Target on AI Prospects
Apple shares edged lower in after-hours trading, while Bernstein raised its price target to $340, highlighting upcoming AI features and rising memory costs as key investor focuses.
Palo Alto Networks Shares Edge Lower as CyberArk Acquisition Nears Deadline
Palo Alto Networks stock dipped slightly in extended trading as Nasdaq set a halt for CyberArk ahead of the merger's expected close. Stifel reduced its price target ahead of earnings.
